What this study is
The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.
What's being tested
- ROCKS
Intervention · BEHAVIORAL
The intervention will be provided to participants to strengthen optimism, communication skills, knowledge, and self-efficacy to support patients and family caregivers in engaging in advance care planning discussions.
- Usual Care
Intervention · BEHAVIORAL
An advance directive called Five Wishes will be provided to participants to increase their knowledge about advance care planning.
Study details
- Official title
- Facilitating Advance Care Planning Discussions Between Patients With Advanced Cancer and Their Family Caregivers Using a Resilience-Building Intervention: A Randomized Controlled Trial.
- Sponsor
- University of Illinois at Chicago
- Conditions
- Advanced Cancer · End of Life
- Enrolling
- 152 people
- Starts
- 2026-06-09
- Est. completion
- 2028-07-31
- Design
- Triple-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Eligible patients will (1) be ≥ 18 years of age; (2) be diagnosed with stage 3 or 4 cancer; and (3) have a family caregiver who is willing to participate.
- Eligible family caregivers will be ≥ 18 years of age. All participants must be able to read, write, and speak English with minimal assistance from others and have access to the internet on a smartphone, laptop, or computer.
You can't join if
- Patient participants will be ineligible if they have (1) a Short Portable Mental Status Questionnaire (SPMSQ) score < 8; or (2) have completed any form of advance directive.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Illinois Chicago
Chicago, Illinois, United States
- Li-Ting H. Longcoy · Contact312-996-3024liting@uic.edu
Recruiting
Study team
Sponsor
University of Illinois at Chicago
Study ID 2023-0430: Aim 4-6
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.